Riskpilot← Back to searchSign inGet full accessTFS Trial Form Support Oy
OYActiveY-tunnus 1776835-8Vähätalontie 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 2002— employees
Revenue 2024
EUR 345K
-80% vs 2023
EBITDA margin
-71.0%
-161% vs 2023
Equity ratio
77.3%
Financial strength
Net profit 2024
EUR -224K
-168% vs 2023
| Revenue | EUR 345K | -80% |
| EBITDA | EUR -244K | -161% |
| Net profit | EUR -224K | -168% |
| Total assets | EUR 487K | -44% |
| Equity | EUR 376K | -37% |
| Employees | — | — |
Legal name
TFS Trial Form Support Oy
Y-tunnus number
1776835-8
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. elokuuta 2002
Share capital
EUR 8 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja toimitusjohtaja yhdessä
Company purpose
TFS Trial Form Support Oy skall på konsultbasis planera, koordinera, genomföra och registrera kliniska prövningar inom "life science"-industrin och bedriva därmed förenlig verksamhet.
Address
Vähätalontie 4
Phone
+3580207731200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 524 | 1 386 | 2 225 | 1 723 | 345 |
| Staff expenses | −628 | −1 009 | −1 030 | −643 | −495 |
| EBITDA | 63 | −301 | 124 | 404 | −244 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 63 | −301 | 124 | 404 | −244 |
| Net financials | −0 | −2 | −2 | 8 | 20 |
| Profit before tax | 62 | −303 | 122 | 412 | −224 |
| Tax | 2 | 2 | 0 | 47 | −0 |
| Net profit | 60 | −305 | 158 | 329 | −224 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 082 | 543 | 999 | 868 | 487 |
| Equity | 419 | 114 | 271 | 600 | 376 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 663 | 429 | 728 | 264 | 109 |
| Total debt | 663 | 429 | 728 | 268 | 110 |
EBITDA margin
-71.0%
This company
15.8%
Market median
-549% vs market
20202024
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
-59.6%
This company
18.4%
Market median
-424% vs market
20202024
Net profit margin
-65.0%
This company
8.1%
Market median
-902% vs market
20202024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NO Person with significant control | Person with significant control | 2018 |
PM Deputy Member | Deputy Member | 2025 |
| Former (5) | ||
DS Person with significant control | Person with significant control | 2018 – 2020 |
JG Person with significant control | Person with significant control | 2018 – 2020 |
JF Chief Executive Officer | Chief Executive Officer | 2018 – 2020 |
BR Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
PJ | Audit | 2015 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
| Former (4) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2018 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TFS Trial Form Support Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niina Orvokki Laaksonen | Person with significant control | 0 companies |
| Daniel Spasic | Person with significant control | 0 companies |
| Jan Gunnar Hellqvist | Person with significant control | 0 companies |
| János Filakovský | Chief Executive Officer | 0 companies |
| Patrik Mikael Polo Darsund | Deputy Member | 0 companies |
| Bassem Radwan Saleh | Chief Executive Officer | 0 companies |
| Pasi Johannes Pekkarinen | Audit | 0 companies |
| Nina Henriette Holst | Board of Directors | 0 companies |
| Jesper Hjort | Board of Directors | 0 companies |
| Lars Gunnar Tordson Wadell | Board of Directors | 0 companies |
| René Holmen Pedersen | Board of Directors | 0 companies |
| Ryan Shortreed | Board of Directors | 0 companies |